IS6478A - Tálmar nýmyndunar kólesteról- og vax-estera til meðhöndlunar á fitukirtilstruflunum - Google Patents

Tálmar nýmyndunar kólesteról- og vax-estera til meðhöndlunar á fitukirtilstruflunum

Info

Publication number: IS6478A
Authority: IS; Iceland
Prior art keywords: liposuction; cholesterol; disorders; treatment; synthesis inhibitors
Prior art date: 2000-02-02

Application number

IS6478A

Other languages

English (en)

Inventor

Homan Reynold

Original Assignee

Warner-Lambert Company , Delaware Corporation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-02

Filing date

2002-07-19

Publication date

2002-07-19

2002-07-19 Application filed by Warner-Lambert Company , Delaware Corporation filed Critical Warner-Lambert Company , Delaware Corporation

2002-07-19 Publication of IS6478A publication Critical patent/IS6478A/is

Links

HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title 2
239000004164 Wax ester Substances 0.000 title 1
230000015572 biosynthetic process Effects 0.000 title 1
235000012000 cholesterol Nutrition 0.000 title 1
239000003112 inhibitor Substances 0.000 title 1
238000007443 liposuction Methods 0.000 title 1
238000003786 synthesis reaction Methods 0.000 title 1
235000019386 wax ester Nutrition 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Emergency Medicine (AREA)
Epidemiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

IS6478A 2000-02-02 2002-07-19 Tálmar nýmyndunar kólesteról- og vax-estera til meðhöndlunar á fitukirtilstruflunum IS6478A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US17977800P	2000-02-02	2000-02-02
PCT/US2001/002190 WO2001056556A2 (en)	2000-02-02	2001-01-23	Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders

Publications (1)

Publication Number	Publication Date
IS6478A true IS6478A (is)	2002-07-19

Family

ID=22657957

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6478A IS6478A (is)	2000-02-02	2002-07-19	Tálmar nýmyndunar kólesteról- og vax-estera til meðhöndlunar á fitukirtilstruflunum

Country Status (34)

Country	Link
US (2)	US6730703B2 (is)
EP (1)	EP1263421B1 (is)
JP (1)	JP2003531113A (is)
KR (1)	KR20020073574A (is)
CN (1)	CN1398182A (is)
AP (1)	AP2002002612A0 (is)
AT (1)	ATE295724T1 (is)
AU (1)	AU781563B2 (is)
BG (1)	BG107042A (is)
BR (1)	BR0107954A (is)
CA (1)	CA2398219A1 (is)
CR (1)	CR6712A (is)
DE (1)	DE60110897T2 (is)
DZ (1)	DZ3288A1 (is)
EA (1)	EA004255B1 (is)
EE (1)	EE200200429A (is)
ES (1)	ES2239145T3 (is)
GE (1)	GEP20043286B (is)
HR (1)	HRP20020717A2 (is)
HU (1)	HUP0301010A3 (is)
IL (1)	IL150865A0 (is)
IS (1)	IS6478A (is)
MA (1)	MA26872A1 (is)
MX (1)	MXPA02007309A (is)
NO (1)	NO20023659L (is)
NZ (1)	NZ520330A (is)
OA (1)	OA12173A (is)
PL (1)	PL357041A1 (is)
PT (1)	PT1263421E (is)
SK (1)	SK10972002A3 (is)
UA (1)	UA75345C2 (is)
WO (1)	WO2001056556A2 (is)
YU (1)	YU57502A (is)
ZA (1)	ZA200206075B (is)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1281399A3 (en) *	2001-08-01	2004-02-11	Warner-Lambert Company	Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production
US20050031699A1 (en)	2003-06-26	2005-02-10	L'oreal	Porous particles loaded with cosmetically or pharmaceutically active compounds
DK1673077T3 (da)	2003-10-09	2008-12-08	Warner Lambert Co	Farmaceutiske præparater, der omfatter malonamidderivater til at nedsætte talgproduktion
MX2007010374A (es)	2005-02-24	2007-09-25	Warner Lambert Co	Inhibidor de acat cristalino.
FR2904002A1 (fr) *	2006-07-19	2008-01-25	Galderma Res & Dev S N C Snc	Modulateurs de la lanosterol synthetase dans le traitement de l'acne ou de l'hyperseborrhee
FR2903999B1 (fr) *	2006-07-19	2008-09-05	Galderma Res & Dev S N C Snc	Modulateurs de sc4mol dans le traitement de l'acne ou de l'hyperseborrhee
FR2938342A1 (fr) *	2008-11-13	2010-05-14	Galderma Res & Dev	Ciblage de modulateurs de ces1 et/ou ces3 dans le traitement de l'acne, d'une dermatite seborrheique ou de l'hyperseborrhee
WO2010087964A2 (en)	2009-01-28	2010-08-05	Nanobio Corporation	Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof
BR112020025208A2 (pt) *	2018-06-21	2021-03-09	Dermavant Sciences GmbH	Formulações tópicas de inibidores de dgat1 e seus métodos de uso

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4545977A (en) *	1985-01-11	1985-10-08	G. D. Searle & Co.	Compositions and methods for treating severe acne with isotretinoin
US4751026A (en)	1986-03-24	1988-06-14	Warner-Lambert Company	Substituted anilides of oleic, linoleic, or linolenic acid as inhibitors of acyl-coa:cholesterol acyltransferase
US4722927A (en)	1986-04-28	1988-02-02	Warner-Lambert Company	Pyrimidine amides of oleic or linoleic acid, composition containing them and their use as inhibitors of acyl-CoA cholesterol acyltransferase
JPS6323848A (ja)	1986-07-11	1988-02-01	ワ−ナ−−ランバ−ト・コンパニ−	Ω−（置換フエニルオキシ）−アルカン酸のアリ−ル−およびアラルキルアミド
US4716175A (en)	1987-02-24	1987-12-29	Warner-Lambert Company	Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase
IE61716B1 (en)	1987-06-02	1994-11-30	Warner Lambert Co	Antihyperlipidemic and antiatherosclerotic urea compounds
US5015644A (en)	1987-06-02	1991-05-14	Warner-Lambert Company	Antihyperlipidemic and antiatherosclerotic urea and carbamate compounds
ATE61574T1 (de)	1987-07-02	1991-03-15	Warner Lambert Co	N-((2,6-disubstituierte)-phenyl>-harnstoff und - carbamat-inhibitoren der acyl-coenzym a:cholesterol-acyltransferase.
US5030653A (en)	1988-03-30	1991-07-09	Warner-Lambert Company	Antihyperlipidemic and antiatherosclerotic compounds and compositions
US4868210A (en)	1988-03-30	1989-09-19	Warner-Lambert Company	Antihyperlipidemic and antiatherosclerotic compounds and compositions
US5116848A (en)	1988-03-30	1992-05-26	Warner-Lambert Company	N-(((2,6-disubstituted)phenyl)-n-diarylalkyl)ureas as antihyperlipidemic and antiatherosclerotic agents
US4999373A (en)	1988-03-30	1991-03-12	Warner-Lambert Company	Antihyperlipidemic and antiatherosclerotic compounds and compositions
US4948806A (en)	1988-03-30	1990-08-14	Warner-Lambert Company	Antihyperlipidemic and antiatherosclerotic compounds and compositions
US4923896A (en)	1989-02-09	1990-05-08	Warner-Lambert Company	N-(substituted aryl)-N'-(substituted alkoxy)-ureas and thioureas as antihypercholesterolemic and antiatherosclerotic agents
US5155127A (en)	1989-02-09	1992-10-13	Warner-Lambert Company	N-(substituted aryl)-n'-(substituted alkoxy)-ureas and thioureas as antihypercholesterolemic and antiatherosclerotic agents
US4994465A (en)	1989-02-17	1991-02-19	Warner-Lambert Company	Antihyperlipidemic and antiatherosclerotic trisubstituted urea compounds
AU632809B2 (en)	1989-05-25	1993-01-14	Takeda Chemical Industries Ltd.	Benzocycloalkane benzopyran and benzothiopyran urea derivatives and production thereof
AU629376B2 (en)	1989-08-04	1992-10-01	Mitsubishi Chemical Corporation	1-phenylalkyl-3-phenylurea derivatives
WO1991004027A1 (en)	1989-09-15	1991-04-04	Pfizer Inc.	New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat)
TW205037B (is)	1989-10-06	1993-05-01	Takeda Pharm Industry Co Ltd
JPH05310678A (ja)	1990-01-22	1993-11-22	Mitsubishi Kasei Corp	１−フェニルアルキル−３−フェニル尿素誘導体
US5362878A (en)	1991-03-21	1994-11-08	Pfizer Inc.	Intermediates for making N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT)
ES2125325T3 (es)	1992-01-23	1999-03-01	Pfizer	Derivados de 4-fenil-3-(heteroarilureido)-1,2-dihidro-2-oxoquinolina como agentes antihipercolesterolemicos y antiateroscleroticos.
AU4028393A (en)	1992-05-28	1993-12-30	Pfizer Inc.	New (N)-aryl and (N)-heteroarylurea derivatives as inhibitors of acyl coenzyme a:cholesterol acyl transferase (ACAT)
US5565472A (en)	1992-12-21	1996-10-15	Pfizer Inc.	4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
US5491172A (en)	1993-05-14	1996-02-13	Warner-Lambert Company	N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
US5596001A (en)	1993-10-25	1997-01-21	Pfizer Inc.	4-aryl-3-(heteroarylureido)quinoline derivatves
US5494172A (en) *	1994-05-12	1996-02-27	Miller Compressing Company	Magnetic pulley assembly
US6133326A (en)	1994-08-31	2000-10-17	Pfizer Inc	Compositions and methods for decreasing sebum production
WO1999067258A1 (en) *	1998-06-25	1999-12-29	Tularik Inc.	Arylsulfonanilide phosphates
JP2004513090A (ja) *	2000-09-27	2004-04-30	メルク　エンド　カムパニー　インコーポレーテッド	糖尿病及び脂質異常症の治療のためのベンゾピランカルボン酸誘導体

2001
- 2001-01-23 EP EP01948936A patent/EP1263421B1/en not_active Expired - Lifetime
- 2001-01-23 NZ NZ520330A patent/NZ520330A/en unknown
- 2001-01-23 US US10/182,847 patent/US6730703B2/en not_active Expired - Fee Related
- 2001-01-23 AP APAP/P/2002/002612A patent/AP2002002612A0/en unknown
- 2001-01-23 DE DE60110897T patent/DE60110897T2/de not_active Expired - Fee Related
- 2001-01-23 PT PT01948936T patent/PT1263421E/pt unknown
- 2001-01-23 UA UA2002076160A patent/UA75345C2/uk unknown
- 2001-01-23 BR BR0107954-9A patent/BR0107954A/pt not_active Application Discontinuation
- 2001-01-23 CN CN01804520A patent/CN1398182A/zh active Pending
- 2001-01-23 HR HR20020717A patent/HRP20020717A2/hr not_active Application Discontinuation
- 2001-01-23 ES ES01948936T patent/ES2239145T3/es not_active Expired - Lifetime
- 2001-01-23 DZ DZ013288A patent/DZ3288A1/fr active
- 2001-01-23 MX MXPA02007309A patent/MXPA02007309A/es active IP Right Grant
- 2001-01-23 CA CA002398219A patent/CA2398219A1/en not_active Abandoned
- 2001-01-23 PL PL01357041A patent/PL357041A1/xx not_active Application Discontinuation
- 2001-01-23 IL IL15086501A patent/IL150865A0/xx unknown
- 2001-01-23 YU YU57502A patent/YU57502A/sh unknown
- 2001-01-23 AT AT01948936T patent/ATE295724T1/de not_active IP Right Cessation
- 2001-01-23 WO PCT/US2001/002190 patent/WO2001056556A2/en not_active Ceased
- 2001-01-23 GE GEAP20016597A patent/GEP20043286B/en unknown
- 2001-01-23 AU AU29718/01A patent/AU781563B2/en not_active Ceased
- 2001-01-23 OA OA1200200234A patent/OA12173A/en unknown
- 2001-01-23 JP JP2001556248A patent/JP2003531113A/ja active Pending
- 2001-01-23 EA EA200200764A patent/EA004255B1/ru not_active IP Right Cessation
- 2001-01-23 SK SK1097-2002A patent/SK10972002A3/sk not_active Application Discontinuation
- 2001-01-23 KR KR1020027009943A patent/KR20020073574A/ko not_active Ceased
- 2001-01-23 HU HU0301010A patent/HUP0301010A3/hu unknown
- 2001-01-23 EE EEP200200429A patent/EE200200429A/xx unknown
2002
- 2002-07-19 IS IS6478A patent/IS6478A/is unknown
- 2002-07-24 CR CR6712A patent/CR6712A/es not_active Application Discontinuation
- 2002-07-30 ZA ZA200206075A patent/ZA200206075B/en unknown
- 2002-08-01 NO NO20023659A patent/NO20023659L/no not_active Application Discontinuation
- 2002-08-01 MA MA26756A patent/MA26872A1/fr unknown
- 2002-08-29 BG BG107042A patent/BG107042A/bg unknown
2004
- 2004-02-06 US US10/773,354 patent/US20040161393A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2398219A1 (en)	2001-08-09
IL150865A0 (en)	2003-02-12
EA200200764A1 (ru)	2002-12-26
SK10972002A3 (sk)	2003-07-01
ZA200206075B (en)	2003-10-30
ES2239145T3 (es)	2005-09-16
AP2002002612A0 (en)	2002-09-30
NO20023659D0 (no)	2002-08-01
YU57502A (sh)	2006-01-16
PT1263421E (pt)	2005-08-31
WO2001056556A3 (en)	2002-03-07
BG107042A (bg)	2003-04-30
NO20023659L (no)	2002-09-25
US6730703B2 (en)	2004-05-04
BR0107954A (pt)	2002-10-22
US20040161393A1 (en)	2004-08-19
CN1398182A (zh)	2003-02-19
EP1263421A2 (en)	2002-12-11
HUP0301010A2 (hu)	2003-08-28
NZ520330A (en)	2004-02-27
MXPA02007309A (es)	2002-11-29
ATE295724T1 (de)	2005-06-15
AU2971801A (en)	2001-08-14
CR6712A (es)	2004-01-14
KR20020073574A (ko)	2002-09-27
PL357041A1 (en)	2004-07-12
OA12173A (en)	2006-05-08
DE60110897T2 (de)	2006-03-23
DZ3288A1 (en)	2001-08-09
AU781563B2 (en)	2005-06-02
EE200200429A (et)	2003-12-15
HUP0301010A3 (en)	2005-03-29
MA26872A1 (fr)	2004-12-20
UA75345C2 (en)	2006-04-17
GEP20043286B (en)	2004-07-26
EA004255B1 (ru)	2004-02-26
JP2003531113A (ja)	2003-10-21
HRP20020717A2 (en)	2003-12-31
US20030060507A1 (en)	2003-03-27
EP1263421B1 (en)	2005-05-18
WO2001056556A2 (en)	2001-08-09
DE60110897D1 (de)	2005-06-23

Publication	Publication Date	Title
ATE344027T1 (de)	2006-11-15	Fettsäurederivat zur behandlung von externen sekretionsstörungen
NO20035610L (no)	2004-02-17	Fremgangsmate for behandling av vaeskeformig hydrokarbon
NO20026008L (no)	2002-12-13	Fremgangsmåte for behandling av cardiovaskul¶re sykdommer
AU9287401A (en)	2002-04-08	Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
DE60224163D1 (de)	2008-01-31	Kombinationen von ezetimibe und aspirin zur behandlung von kardiovaskulären erkrankungen
NO20021845D0 (no)	2002-04-19	Behandling av sövnforstyrrelser under anvendelse av desloratadin
NO20015112L (no)	2001-12-10	Anvendelse av glykosylceramidsynteseinhibitorer ved terapi
IS6609A (is)	2002-11-07	Aðferð til framleiðslu á díhýdroxýesterum og afleiðum þeirra
NO20024775D0 (no)	2002-10-03	Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
ZA200206032B (en)	2004-02-10	Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production.
IS6137A (is)	2001-10-30	Meðhöndlun á hugsýkistruflunum
IS6478A (is)	2002-07-19	Tálmar nýmyndunar kólesteról- og vax-estera til meðhöndlunar á fitukirtilstruflunum
NO20024776D0 (no)	2002-10-03	Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte
NO20024777L (no)	2002-12-03	Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
IS3004B (is)	2018-09-15	Aðferð til meðhöndlunar á svefnleysi á frumstigi
ATE430577T1 (de)	2009-05-15	Ppar delta-inhibitoren zur behandlung kardiovasculärer erkrankungen
NO20032156L (no)	2003-05-13	Behandling av angstforstyrrelser
IL169489A0 (en)	2007-07-04	Use of derivatives of succinate esters for the treatment of dementia
NO20023803D0 (no)	2002-08-09	Anvendelse av mirtazapin for behandling av sövnforstyrrelser
IS6098A (is)	2001-09-28	Ósantant til meðhöndlunar á skaptruflunum
NO20030717L (no)	2003-02-14	Forbindelser for behandling av avhengighetsforstyrrelser
EP1330271A4 (en)	2005-11-09	USE OF TRANSCRIPTION FACTORS IN THE TREATMENT OF INFLAMMATION AND OTHER DISEASES
NO20010569D0 (no)	2001-02-02	Proteaseinhibitorer for anvendelse ved behandling av psoriasis
NO20024331D0 (no)	2002-09-10	Behandling av lidelser relatert til det serotonerge system
IS2153B (is)	2006-10-13	S-nítrósóþíól til meðferðar við blóðrásartruflunum